Research ReportsGlobal Health - Witnessing Recovery In Developing Hospitals: Motilal Oswal
ADVERTISEMENT
Global Health - Witnessing Recovery In Developing Hospitals: Motilal Oswal
The brokerage values the company at 33 times 12 months forward enterprise value/Ebitda to arrive at a target price of Rs 1,380 and reiterates Buy on the stock.
Medanta hospital building. (Source: Company website)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.